Contract Pharma

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

AMRI Contributes to Efforts to Increase COVID-19 Vax Supply

Joins network of approved manufacturers of lipid excipients for Pfizer-BioNTech COVID-19 vaccine.

Tim Wright, Editor, Contract Pharma 02.25.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Information Technology

Pfizer Selects Seven Bridges to Support RNA Sequencing Data

Seven Bridges will centralize and manage terabytes scRNASeq data, which provides detailed analysis of gene expression in individual cells.

Kristin Brooks 02.24.21

Catalent Acquires Delphi Genetics

Launches US plasmid manufacturing site to establish global pDNA development and manufacturing capabilities.

Tim Wright, Editor, Contract Pharma 02.23.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Avid Bioservices Begins Phase 2 of Myford Mfg. Expansion

Build to include second manufacturing train with both upstream and downstream processing suites.

Kristin Brooks 02.22.21

MaxiVAX, Minaris Enter Cell Therapy Mfg. Agreement

Minaris will provide GMP manufacturing, freezing and shipping of the MVX-ONCO-2 capsules from its site near Munich, Germany.

Kristin Brooks 02.22.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

G-CON Manufacturing Delivers & Installs PODs for Cell Therapy Manufacturing

Successfully completes the project within the client’s required schedule.

Charles Sternberg, Assistant Editor 02.19.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Intravacc Unveils New Pilot Vaccine Production Facility

State-of-the-art pilot plant for production of vaccine candidates in clinical phase I & II research.

Tim Wright, Editor, Contract Pharma 02.19.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Century Therapeutics Significantly Expands Capabilities

Unveils new operational, laboratory and manufacturing facilities in Pennsylvania and New Jersey.

Tim Wright, Editor, Contract Pharma 02.19.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Pfizer, BioNTech To Supply 200M More Vax Doses to EU

New agreement brings total supply to the European Union to 500 million doses, with delivery expected by the end of 2021.

Charles Sternberg, Assistant Editor 02.17.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Novavax, SK Bioscience Expand Vax Pact

The existing partnership for manufacture of NVX-CoV2373 has been expanded to increase production capacity and supply vaccines to the Korean Government.

Charles Sternberg, Assistant Editor 02.17.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News

Charles River Acquires CDMO Cognate BioServices

Pays roughly $875 million to significantly expand capabilities in the cell and gene therapy sector.

Tim Wright, Editor, Contract Pharma 02.17.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News

Kaneka Eurogentec Expands Capabilities

Receives GMP accreditation for new mRNA manufacturing facility, COVID-19 vaccine production ongoing.

Tim Wright, Editor, Contract Pharma 02.17.21

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development

Biomunex, Onward Ink Strategic Antibody Development Pact

Exclusive worldwide license and development agreement will leverage Biomunex' next gen bi- and multi-specific antibody platform in hematological malignancies.

Kristin Brooks 02.16.21

APIs | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

FUJIFILM Diosynth Hosts UK PM at COVID Vax Mfg. Site

Billingham site to support the manufacture of up to 180 million doses Novavax’ NVX-CoV2373 COVID-19 vaccine candidate.

Kristin Brooks 02.16.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Pfizer, BioNTech to Supply the U.S. with 100mn Additional Doses of COVID-19 Vaccine

U.S. government exercises option to bring total supply to 300 million doses, enabling vaccinations for 150 million people.

Tim Wright, Editor, Contract Pharma 02.12.21

Biologics, Proteins, Vaccines | Breaking News | Industry News

Evonik Strengthens Partnership with BioNTech on COVID-19 Vaccine

Establishment of additional lipid production in Germany for use with mRNA-based vaccines.

Tim Wright, Editor, Contract Pharma 02.12.21

Aseptic Processing | Biologics, Proteins, Vaccines | Injectables

Seasonal Vaccine Manufacturing

There are three areas to evaluate when selecting an outsourcing partner for seasonal vaccine manufacturing.

Biologics, Proteins, Vaccines | Collaborations & Alliances | Drug Development

Molecular Templates, BMS Enter Strategic Research Pact

Aims to discover and develop multiple therapies for specific oncology targets utilizing MTEM’s next-gen engineered toxin body (ETB) platform.

Kristin Brooks 02.11.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News

Recipharm Bolsters Biologics Offering

Extends manufacturing license to include immunology products at clinical and commercial scales, in both freeze-dried and liquid forms.

Kristin Brooks 02.11.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Rentschler Biopharma Establishes Cell and Gene CoE

Aims to address the gap in capacity and support for early-stage innovators in cell and gene therapy.

Kristin Brooks 02.11.21

AbbVie, Caribou Ink CAR-T Collaboration

Leverages Caribou's next-generation CRISPR genome editing technology platform and AbbVie's antigen-specific binders.

Tim Wright, Editor, Contract Pharma 02.10.21

Biologics, Proteins, Vaccines | Breaking News

RotaChrom Technologies Partners with Cyclolab

Aims to develop a more efficient and cost-effective process to purify Remdesivir, a widely used treatment option for COVID-19.

Charles Sternberg, Assistant Editor 02.09.21

Thermo Fisher, JW Therapeutics Form CAR-T Partnership in China

Companies join forces in cell therapy applications and commercial-scale manufacturing.

Tim Wright, Editor, Contract Pharma 02.08.21

Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Vigene Plans Major Expansion in Maryland

Global gene therapy and vaccine manufacturing company taking additional space in Rockville and adding up to 245 jobs.

Tim Wright, Editor, Contract Pharma 02.08.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Paragon Biosciences Expands Cell and Gene Therapy Platform

Launches CiRC Biosciences with an initial focus on developing eye disease treatments.

Tim Wright, Editor, Contract Pharma 02.08.21

Catalent, Trizell Enter Cell Therapy Deal

Sign development and manufacturing agreement with for macrophage-based advanced cell therapy.

Tim Wright, Editor, Contract Pharma 02.08.21

Biologics, Proteins, Vaccines | Clinical Trials

Inside a Vaccine Trial

Dr. Murphy of ICON, provider of clinical services to Pfizer/BioNTech’s COVID vaccine program, discusses what it takes to conduct a vaccine trial of this scale.

Online Exclusives Kristin Brooks, Managing Editor 02.05.21

Biologics, Proteins, Vaccines | Breaking News | Industry News

CureVac, UK Partner on Vaccines Against SARS-CoV-2 Variants

Aims to mitigate the effects of the pandemic and help prepare against future SARS-CoV-2 outbreaks by working on multiple variant vaccines.

Kristin Brooks 02.05.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings

J&J Submits EUA for Single-Shot Janssen COVID Vax Candidate

Plans to distribute vaccine to U.S. government immediately following authorization, and expects to supply 100 million doses in 1H21.

Kristin Brooks 02.05.21

Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development

The Future of Vaccines and Biologics

Dr. Linda Marbán of Capricor Therapeutics discusses the advances in responding to infectious diseases.

Online Exclusives Kristin Brooks, Managing Editor, Contract Pharma 02.04.21

Catalent, Decibel Team Up for Hearing Loss Treatment

Enter development and manufacturing agreement for dual-vector gene therapy for the treatment of congenital hearing loss.

Tim Wright, Editor, Contract Pharma 02.04.21

Wacker Strengthens Biologics Business

Acquires US-based plasmid DNA manufacturer Genopis.

Tim Wright, Editor, Contract Pharma 02.04.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings

Vaxart Oral COVID-19 Vax Tablet Shows Promise

Phase I study reached primary and secondary endpoints of safety and immunogenicity.

Kristin Brooks 02.03.21

Immunome, Abzena Enter COVID-19 Antibody Cocktail Agreement

Abzena will work with Immunome to produce the antibody cocktail for clinical testing.

Kristin Brooks 02.03.21

Avid, Humanigen Enter Lenzilumab Mfg. Agreement

To expand production capacity for lenzilumab, Humanigen’s therapeutic candidate in development to treat cytokine storm associated with COVID-19.

Kristin Brooks 02.03.21

Biologics, Proteins, Vaccines | cGMP Manufacture | Collaborations & Alliances

GSK, CureVac Enter New €150M COVID Vax Pact

GSK will support the manufacture of up to 100 million doses of CureVac’s first generation COVID-19 vaccine candidate CVnCoV in 2021.

Kristin Brooks 02.03.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Just, Evotec Expand mAbs Manufacturing Contract with DOD

Will manufacture anti-SARS-CoV-2 and other antibodies at J.POD facility in Washington state.

Tim Wright, Editor, Contract Pharma 02.02.21

Biologics, Proteins, Vaccines | Breaking News

UK Secures 40M Doses of Valneva COVID-19 Vax

Brings the total volume of the Valneva vaccine ordered by UK Government to 100 million doses.

Charles Sternberg, Assistant Editor 02.01.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

CureVac, Rentschler Ramp up COVID Vax Production

Rentschler responsible for manufacturing, downstream processing and formulation of CureVac’s CVnCoV in Laupheim, Germany.

Kristin Brooks 02.01.21

Biologics, Proteins, Vaccines | cGMP Manufacture | Facilities | Parenterals

Making the Switch to Single-Use Technologies

Why Avid Bioservices adopted single-use technologies over thirteen years ago and never looked back.

Contract Pharma Staff

Cognate BioServices, Nucleus Biologics Form Cell & Gene Therapy Partnership

Will focus on clinical and commercial clients, especially as Cognate expands its business with allogeneic and autologous on-demand cell and gene therapies.

Tim Wright, Editor, Contract Pharma 01.29.21

Novartis Inks Contract Manufacturing Deal for Pfizer-BioNTech COVID-19 Vaccine

Novartis to leverage manufacturing capacity and capabilities to address pandemic, supporting global supply of COVID-19 vaccine.

Tim Wright, Editor, Contract Pharma 01.29.21

Evozyne, Takeda Ink Strategic Protein Design Agreement

Takeda will use Evozyne's evolution-based protein design technology to research and develop proteins for next-gen gene therapies.

Kristin Brooks 01.28.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Lonza Launches Cryopreserved Leukopaks

Customizable cryopreserved Leukopaks aim to provide greater flexibility in immunology and cell therapy research.

Kristin Brooks 01.28.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Valneva Begins COVID Vax Production to Optimize Potential Deliveries

Inactivated, adjuvanted COVID-19 vaccine candidate is in Phase 1/2 clinical development with initial results in April 2021.

Kristin Brooks 01.28.21

Biologics, Proteins, Vaccines

Vaccines 2021

Looking at the behavioral economics of vaccinations.

Ben Locwin, Contributing Editor 01.27.21

Biologics, Proteins, Vaccines

The Future of Biologics: Accelerating Production, Reducing Costs

Yeast-based gene expression offers pharma the yield and efficiencies it needs to make pandemic-stopping vaccines faster and more economical.

Mark Emalfarb, Dyadic 01.27.21

Biologics, Proteins, Vaccines | Regulatory Affairs

The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

A look at EUA standards and approvals, unavoidable pitfalls, Operation Warp Speed, FDA’s use of Real-World Evidence, and a slow return to “normalcy.”

Chad Landmon, Michelle Divelbiss and Alex Alfano, Attorneys - Axinn, Veltrop & Harkrider LLP 01.27.21

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development

Lilly, Vir, GSK Partner to Evaluate COVID Combo Therapies

Lilly expands BLAZE-4 trial to evaluate bamlanivimab with VIR-7831, two neutralizing antibodies that bind to different epitopes of the SARS-CoV-2 spike protein.

Kristin Brooks 01.27.21